Admissions Open

Toll Free : 1800 2740 240

Name of Journal: Pharmaceutical Nanotechnology

Development of polymeric micelles for the management of the allergic conjunctivitis to overcome the limitations of topical installation such as poor patient compliance, poor stromal permeability, and increase residence time, efficacy and also control the release of drug at target site. A controlled release pH-sensitive ocular formulation capable of carrying drug to the anterior section of the eye via topical delivery was successfully developed for the treatment of allergic conjunctivitis.

Admission Enquiry 2020

Skip to content Skip to content